ETF Series Solutions - Loncar China BioPharma ETF Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
No updates
CEO
ETF Series Solutions - Loncar China BioPharma ETF has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Portfolio Manager | no data | no data | no data | |
| Portfolio Manager | no data | no data | no data | |
| Portfolio Manager | no data | no data | no data | |
| Portfolio Manager | no data | no data | no data |
0.5yrs
Average Tenure
Experienced Management: CHNA's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.